FNY Managed Accounts’s Pulse Biosciences PLSE Stock Holding History

FNY Managed Accounts’s Portfolio PLSE Stock Details PLSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-1,001	Closed	-$20K	–	501
2017 Q1	$20K	Buy	+1,001	New	+$13.6K	0.06%	354

Other funds holding PLSE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TIAA FSB Jacksonville, Florida $27.6B AUM 14.26% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FNY Managed Accounts's PLSE Position: Q2 2017 in Review

FNY Managed Accounts sold out of Pulse Biosciences (PLSE) in Q2 2017, closing a stake of 1,001 shares — an estimated $20K sold.

FNY Managed Accounts first reported a position in PLSE in Q1 2017 and held it in 1 quarter. The position peaked at $20K in Q1 2017. 49 funds tracked by Wall St. Rank hold PLSE as of Q2 2017.

FNY Managed Accounts reported no remaining Pulse Biosciences position as of Q2 2017 after selling out during the quarter.
FNY Managed Accounts sold 1,001 Pulse Biosciences shares in Q2 2017, an estimated $20K.
FNY Managed Accounts first reported a position in Pulse Biosciences in Q1 2017 and held it in 1 quarter.
FNY Managed Accounts's Pulse Biosciences position peaked at $20K in Q1 2017.
49 funds tracked by Wall St. Rank held Pulse Biosciences as of Q2 2017.

Based on FNY Managed Accounts's 13F filing for Q2 2017, filed 10 Aug 2017.